Our technology has undergone extensive independent laboratory tests and a five month test trial in three live hospital settings. Based on these reports we guarantee our solution will provide five months of total surface protection. It is effective against Coronavirus as well as many other harmful bacteria and viruses including MRSA, Bird Flu N5N1, E.Coli C.Diff, Tuberculosis, HIV, Legionella Pnuemophila and both Hepatitis B+C.
Our antimicrobial barrier is also effective against the spread of influenza. With the winter Flu season approaching combined with COVID-19, all sites should now have Total Surface Protection.